New Chemistry and Biology Teacher Scholarships: "Olpha" and "Central Laboratory" Have Already Invested 45,000 Euros
On October 24 of this year, at the second annual Science Teachers' Day held by the Latvian pharmaceutical company "Olpha," four new scholarships were awarded to aspiring chemistry and biology teachers, each worth 3,000 euros.
Read more
250 patients will have the opportunity to receive obesity treatment at the “AIWA clinic”
An experienced team of medical professionals from the multi-profile surgical clinic “AIWA Clinic”, part of “Veselības centru apvienība” (VCA), will implement the European Union (EU) funded pilot project “Value-based (VBHC) bariatric service model”, promoted by the National Health Service until October 2025.
Read more
With an Investment of 3.56 Million Euros, "Olpha" Establishes One of the Largest Solar Panel Parks on a Manufacturing Company Site
On Wednesday, October 2, in the presence of the Minister of Climate and Energy, Kaspars Melnis, one of Latvia's largest solar panel parks on a manufacturing company site was inaugurated at the premises of Latvia’s leading pharmaceutical manufacturer, "Olpha".
Read more
Published a textbook on laboratory diagnostics, unique in Latvia
A comprehensive textbook titled “Laboratory investigations for the diagnosis of various diseases” was published this week. This textbook, the first of its kind in Latvia, compiles the most important information on advanced diagnostic tests and their medical interpretation.
Read more
"Olpha's" Corporate Social Responsibility Projects Nominated for Prestigious International Pharmaceuticals Award
The corporate social responsibility projects implemented by Latvia's pharmaceutical company "Olpha" have gained recognition on the global stage. The company has been nominated for the 11th annual "Global Generics and Biosimilars Awards" in the category of "Corporate Social Responsibility." The winners will be announced on October 9 in Milan, Italy.
Read more
“Mēness aptieka”- the most loved, highest quality and most affordable brand in the pharmaceutical sector
“Mēness aptieka” has convincingly secured first place in the largest brand and lifestyle survey in the Baltics, “Brand Capital”, and is recognized as the most loved brand in the pharmaceutical sector. In recent years, there has been a significant increase in the number of people who love and appreciate the brand. At the same time, the brand is growing strongly as respondents acknowledge its quality and affordability.
Read more
Olainfarm transforms into Olpha, aiming to become Europe's TOP 10 pharmaceutical company
Olainfarm JSC, a leading Latvian pharmaceutical company and drug manufacturer, announced a rebranding to Olpha on June 19 The company's development strategy is to grow from a regional player to an international pharmaceutical company and Olpha aims to become one of the top ten pharmaceutical companies in Europe...
Read more
“Mēness aptieka” stresses the importance of environmental factors in maintaining health
Every June, with heart health in mind, “Mēness aptieka” raises important issues about cardiovascular diseases and their prevention, conducts public opinion polls and, in cooperation with doctors and the patient organisation, encourages greater use of prevention options and brings forth important topics for discussions relating to heart health.
Read more
People have laboratory tests as prescribed by their GP or specialist
Residents of Latvia follow the instructions of their doctors and have the tests prescribed by their GP or specialist carried out in a laboratory.
Read more
Pharmacists observe heart surgery at the Latvian Centre of Cardiology
In order to better understand the treatment processes of patients with cardiovascular diseases while providing much needed pharmaceutical care, pharmacists from “Mēness aptieka” met with specialists from the Latvian Centre of Cardiology...
Read more
“Veselības centru apvienība” opens an Early Atherosclerosis and Dyslipidaemia Office
The Early Atherosclerosis and Dyslipidaemia Office has been opened in the “Aura” polyclinic of “Veselības centru apvienība” (VCA).
Read more
Six young chemistry and biology teachers in Latvia are awarded scholarships of 18 000 euros
Latvia faces a shortage of teachers, with a critical situation emerging, particularly in natural sciences and technology (STEM).
Read more
Director of Strategic and Health Policy Joins the Management Team of AB CITY Group
In order to further improve AB CITY Group's operations, Kristine Jučkoviča, Director of Strategic and Health Policy, has joined the management team, complementing the centralised management of functions within the holding company.
Read more
AS AB CITY starts the mandatory buy-back of AS Olainfarm shares
In order to ensure that AS Olainfarm shareholders have the opportunity to receive fair value for their shares, the mandatory buy-back of AS Olainfarm shares is currently taking place. It is being conducted in accordance with the provisions of the Republic of Latvia’s Financial Instrument Market Law, and is being overseen by the Financial and Capital Market Commission (FCMC).
Read more
FCMC allows mandatory Olainfarm share buy-back to go ahead
Today, 3 November, the Repharm Group’s parent company AS AB City has received permission from the Financial and Capital Market Commission (FCMC) to go ahead and make a mandatory AS Olainfarm share buy-back offer.
Read more
AB City submits the Olainfarm share buy-back prospectus to the FCMC
AS AB City has made an application to the Financial and Capital Market Commission (FCMC) to make a mandatory buy-back offer for the shares in AS Olainfarm.
Read more
The Purchase of Olainfarm Shares Announced by AB City Has Been Completed
On Wednesday, August 25, the purchase of Olainfarm shares announced by AB City was completed...
Read more
Olainfarm Share Buyback – Green Light from Court
Today, Olainfarm Share Buyback got another green light from Court and AB City buyback offer to shareholders can go ahead unhampered...
Read more
JSC “AB City” offers to purchase JSC “Olainfarm” shares from shareholders
From 19 to 25 August 2021, JSC “AB City” offers to repurchase JSC “Olainfarm” shares owned by shareholders.
Read more
The mandatory Olainfarm share buy-back concluded
Olainfarm minority shareholders have sold sharesworth almost EUR 22.5 million to AB City
Read more
“AB City” will provide minority shareholders of Olainfarm with an opportunity to sell their shares for the price approved by FCMC
JSC “AB City” appreciates the efforts of the Financial and Capital Market Commission (FCMC) to protect minority shareholders of JSC “Olainfarm”, who wish to use the mandatory share repurchase bid...
Read more
“AB City” announces extension of the tender offer for “Olainfarm” shares
JSC “Repharm” parent company JSC “AB City” has announced its readiness to continue purchasing the JSC “Olainfarm” shares owned by minority shareholders also after the end of the period of the mandatory tender offer for JSC “Olainfarm” shares, expiring on 17 August...
Read more
FCMC permits JSC “AB City” to make a mandatory repurchase offer for shares of JSC “Olainfarm”
The Financial and Capital Market Commission has decided to permit JSC “AB City” to make a mandatory repurchase offer for shares of JSC “Olainfarm”, because JSC “AB City”, based on the indirectly acquired ownership...
Read more
“Repharm” group will ask for FCMC’s permission to make a mandatory share repurchase offer to the shareholders of “Olainfarm”
“Repharm” group has informed Nasdaq Riga of an agreement with Nika Saveļjeva to acquire 7.8% of the voting rights in JSC “Olainfarm” by exercising these rights through JSC “AB City”, the mother company of JSC “Repharm”...
Read more